A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD.

Saved in:
Bibliographic Details
Title: A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD.
Authors: Wells JA, Gonzales CR, Berger BB, Gonzalez VH, Sippy BD, Burian G
Source: Ophthalmic surgery, lasers & imaging retina [Ophthalmic Surg Lasers Imaging Retina] 2018 May 01; Vol. 49 (5), pp. 336-345.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Healio.com Country of Publication: United States NLM ID: 101599215 Publication Model: Print Cited Medium: Internet ISSN: 2325-8179 (Electronic) Linking ISSN: 23258160 NLM ISO Abbreviation: Ophthalmic Surg Lasers Imaging Retina Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2325-8179
DOI:10.3928/23258160-20180501-07